Could Pfizer’s 7.1% Yield Be a Trap?
In The Oxford Clubroom a few weeks ago, I was asked for my thoughts on Pfizer (NYSE: PFE), which has a huge yield…
In The Oxford Clubroom a few weeks ago, I was asked for my thoughts on Pfizer (NYSE: PFE), which has a huge yield…
Editor’s Note: The markets have rebounded nicely over the past week, but there’s no doubt investors are still reeling from the roller coaster…
It’s been a while and our reader cases are piling up, so without further ado, it’s time for another reader case! Greetings FC…
Years ago, during a high school golf match, as I was angrily searching for my ball after an errant tee shot, my coach…
Amkor Technology (Nasdaq: AMKR) might not be a household name, but it plays a crucial role in the semiconductor industry. As the world’s…
The assisted living facility in Edina, Minnesota, where Jean Peters and her siblings moved their mother in 2011, looked lovely. “But then you…
Editor’s Note: Today, I’m excited to announce the latest addition to the Wealthy Retirement website: a new-and-improved commenting system that will allow you…
Last week, I discussed two strategies for generating income in this tough market environment. While selling covered calls and naked puts is a…
A few weeks ago, we did an example of how our portfolio is taxed after retirement, and showed that by constructing a portfolio…